Physician profile
Herb Singh
NPI 1639172281
$2,412.91
in general payments reported to CMS, 2019-2025
26 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $16.23 · 2021: $67.52 · 2022: $287 · 2023: $233 · 2024: $404 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $575.94 | 2019 | |
| Abbvie INC. | $305.24 | 2022-2025 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $285.45 | 2023-2025 | Erleada, Carvykti, Rybrevant |
| Ferring Pharmaceuticals INC. | $178.88 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $165.95 | 2019-2025 | |
| Teleflex LLC | $149.90 | 2022 | |
| Janssen Scientific Affairs, LLC | $138.08 | 2025 | Balversa, Erleada |
| Medtronic, INC. | $95.90 | 2024 | Ligasure |
| Innovation Technologies INC | $68.27 | 2024 | Irrisept |
| Boston Scientific Corporation | $52.66 | 2019-2024 | Rezum Generator |
| Axonics, INC. | $46.81 | 2023 | Axonics |
| Olympus America INC. | $44.31 | 2023-2024 | Itind System |
| Urogen Pharma, INC. | $44.15 | 2024 | |
| Endo USA, INC. | $37.32 | 2025 | Aveed, Xiaflex |
| Rochester Medical Corporation | $30.21 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $29.68 | 2022-2023 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $22.91 | 2021 | |
| Myriad Genetic Laboratories, INC. | $20.43 | 2024 | Prolaris |
| Avadel Specialty Pharmaceuticals, LLC | $19.02 | 2019 | |
| Astellas Pharma US INC | $18.94 | 2019 | |
| Procept Biorobotics Corporation | $16.23 | 2020 | |
| Coloplast Corp | $14.40 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.54 | 2022 | |
| Urovant Sciences INC | $13.10 | 2022 | |
| Amgen INC. | $12.98 | 2022 | |
| Antares Pharma, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herb Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.